Literature DB >> 21691324

Experimental arthritis: Dendrimer drug mends monocytes.

Emma Leah.   

Abstract

Entities:  

Year:  2011        PMID： 21691324     DOI： 10.1038/nrrheum.2011.73

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.

Authors:  Myriam Hayder; Mary Poupot; Michel Baron; Delphine Nigon; Cédric-Olivier Turrin; Anne-Marie Caminade; Jean-Pierre Majoral; Robert A Eisenberg; Jean-Jacques Fournié; Alain Cantagrel; Rémy Poupot; Jean-Luc Davignon
Journal:  Sci Transl Med       Date:  2011-05-04       Impact factor: 17.956
  1 in total
  2 in total

1.  The key role of the scaffold on the efficiency of dendrimer nanodrugs.

Authors:  Anne-Marie Caminade; Séverine Fruchon; Cédric-Olivier Turrin; Mary Poupot; Armelle Ouali; Alexandrine Maraval; Matteo Garzoni; Marek Maly; Victor Furer; Valeri Kovalenko; Jean-Pierre Majoral; Giovanni M Pavan; Rémy Poupot
Journal:  Nat Commun       Date:  2015-07-14       Impact factor: 14.919

Review 2.  The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells.

Authors:  Séverine Fruchon; Rémy Poupot
Journal:  Molecules       Date:  2018-05-25       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.